Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Not Confirmed
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Not Confirmed
Not Confirmed
05-08 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Industry Trade Show
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Industry Trade Show
Not Confirmed
05-08 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-bridge-the-gap-between-chemistry-and-performance-to-deliver-precise-optimized-micronization-for-complex-apis
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
18 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/18/3152494/0/en/Senti-Bio-to-Present-at-the-MedInvest-Biotech-Pharma-Conference.html
02 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/02/3142773/0/en/Senti-Bio-to-Present-at-the-H-C-Wainwright-27th-Annual-Global-Investment-Conference.html
14 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/14/3133567/0/en/Senti-Biosciences-to-Present-at-the-Webull-Financial-Corporate-Connect-Webinar-Series-Biotech-MedTech.html
12 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/12/3131797/0/en/Senti-Bio-Participates-in-Virtual-Investor-What-This-Means-Segment-Discussing-The-Phase-2-Dose-and-Schedule-Selection-for-SENTI-202-in-its-Clinical-Trial-for-Acute-Myeloid-Leukemia.html
07 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/07/3129230/0/en/Senti-Bio-Reports-Second-Quarter-2025-Financial-Results-and-Confirms-Next-Data-Milestone-for-Phase-1-SENTI-202-Study-in-Acute-Myeloid-Leukemia-AML-Expected-Q4-2025.html
05 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/05/3127362/0/en/Senti-Bio-Determines-Recommended-Phase-2-Dose-RP2D-in-Phase-1-Study-of-SENTI-202-for-the-Treatment-of-Relapsed-Refractory-Hematologic-Malignancies-Including-Acute-Myeloid-Leukemia.html
ABOUT THIS PAGE